期刊文献+

肿瘤综合治疗中的循证医学和个体化治疗 被引量:7

Evidence-based medicine and individualization treatment in the combined therapy of tumor
原文传递
导出
摘要 现代医学模式已经由单纯的生物医学模式转变为'生物-心理-社会'医学模式,由经验医学转变为以证据为基础的循证医学(EBM),这一指导临床医学实践的新模式,在肿瘤的综合治疗中起到了重要的指导作用;同时'个体化治疗'也是肿瘤综合治疗中不可忽视的原则之一,在肿瘤的治疗中占有越来越重要的地位.在实际的临床工作中,'循证医学'和'个体化治疗'这两个概念并非相互对立,而是相辅相成、密不可分的,现代肿瘤专科医师,必须掌握这些概念并在实际工作中努力贯彻、综合运用,才能制定合理的肿瘤综合治疗方案,最大限度维护患者的利益、得到最佳的治疗效果. Malignant tumor is one of the principle diseases which threatens the health of human being, and its incidence rate has been dramatically increased in recent years.Modern medical model has transformed from biomedical model to the model of "biology-psychology-society",from experience-based medicine to evidence-based medicine (EBM).At the same time,individualization is also one of important principles of tumor combined therapy.EBM and individualization treatment are not to opposed to each other but to complement each other. This article expounded the relationship of EBM and individualization treatment in tumor therapy,and showed that both of these two principles must be grasped arid carried out in clinical work.
出处 《肿瘤研究与临床》 CAS 2008年第3期145-147,共3页 Cancer Research and Clinic
  • 相关文献

参考文献6

二级参考文献14

  • 1McLeod H L,Evans W E:Pharmacogenomics:Unlocking the Human Genome for Better Drug Therapy[J].Annu Rev Pharmacol Toxicol,2001,41(1):101-121.
  • 2Williams R J.Biochemical individuality-the Basis for the Genetotrophic Concept[M].New York:John Wiley & Sons,Inc,1956.195.
  • 3Fischel-Ghodsian N.Mitochondrial DNA mutations and diabetes:another step toward individualized medicine[J].Ann Intern Med,2001,134(9 Pt I):777-779.
  • 4Sasaki K,Kawauchi S.Molecular cytogenetic analysis of solid tumors[J].J Orthop Sci,2003,8(3):457-459.
  • 5Cohen I,Tagliaferri M,Tripathy D.Traditional Chinese medicine in the treatment of breast cancer[J].Semin Oncol,2002,29(6):563-574.
  • 6Calvo K R,Liotta L A,Petricoin E F.Clinical proteomics:from biomarker discovery and cell signaling profiles to individualized personal therapy[J].Biosci Rep,2005,25(1-2):107-125.
  • 7Ross J S,Ginsburg G S.Integration of molecular diagnostics with therapeutics:implications for drug discovery and patient care[J].Expert Rev Mol Diagn,2002,2(6):531-541.
  • 8Jain K K.Personalized medicine[J].Curr Opin Mol Ther,2002,4(6):548-558.
  • 9Evans W E,McLeod H L.Pharmacogenomics-Drug Disposition,Drug Targets,and Side Effects[J].N Engl J Med,2003,348(6):538-549.
  • 10Fierz W.Challenge of personalized health care:to what extent is medicine already individualized and what are the future trends?[J].Med Sci Monit,2004,10(5):RA111-123.

共引文献20

同被引文献44

  • 1于莎丽.关于过度医疗伦理分析的再思考[J].中国医学伦理学,2007,20(2):43-44. 被引量:15
  • 2Williams RJ.Biochemical individuality-the basis for the gene-totrophic concept.New York:John Wiley & Sons,Inc,1956.
  • 3Fischel-Ghodsian N.Mitochondrial DNA mutations and diabetes:another step toward individualized medicine.Ann Intern Med,2001,134(9 Pt1):721-728.
  • 4Schrfider FH, Hugosson J, Roobol MJ, et al. Screen- ing and prostate -cancer mortality in a randomized European study[J]. N Engl J Med,2009,360(13) : 1320 - 1328.
  • 5Klotz L. Cancer overdiagnosis and overtreatment [J]. Curr Opin Urol, 2012,22(3):203 -209.
  • 6杨跃进.循证医学时代的尴尬与对策[N].健康报,2012-04-09.
  • 7Subbiah MT. Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine [J]. Transl Res, 2007,149 (2) :55-61.
  • 8Hood L. Systems biology and P4 medicine: past, present, and future [ J ]. Rambam Maimonides Med J, 2013,4 (2) : e0012.
  • 9Giacomini KM, Krauss RM, Roden DM, et al. When good drugs go bad [J]. Nature, 2007,446(7139) : 975-977.
  • 10Miller BW, Moore JW, Barrett HH, et al. 3D printing in X-ray and Gamma-Ray Imaging: a novel method for fabricating high- density imaging apertures [J]. Nucl Instrum Methods Phys Res A, 2011,659(1) :262-268.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部